Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04940611 · ClinicalTrials.gov registry record
A Study of Surgical Interventions in Fistulizing Conditions
A clinical trial of Crohn's Disease and Fistula, sponsored by Takeda.
- Active
- Registry status
- 750
- Enrollment target
- 20
- Study locations
NCT04940611 is a study of Crohn's Disease and Fistula that is active but no longer recruiting, run by Takeda. The registered enrollment target is 750 participants, below the 2,407-participant average among 104 other Crohn's Disease trials with a reported enrollment target (69% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT04940611, a study of Crohn's Disease and Fistula, is active but no longer recruiting, sponsored by Takeda.
- ACTIVE NOT RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 20
- Study locations
Study Summary
In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The aim of the study is to generate real-world evidence on standard of care for surgical interventions and related outcomes when treating complex fistulizing conditions. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study.
Conditions Studied
Study Locations (20)
Other
- AKH - Medizinische Universitat Wien - Vienna
- UZ Antwerpen - Antwerp
- Cliniques Universitaires Saint-Luc - Brussels
- Jessa Ziekenhuis Hospital - Hasselt
- Clinique CHC MontLegia - Liège
- AZ Delta - Roeselare
Florida
- Baptist MD Anderson Cancer Center - Jacksonville
- University of South Florida - PARENT - Tampa
Pennsylvania
- Penn Medicine PA - Philadelphia
- Temple University Hospital - Philadelphia
Texas
- Baylor Research Institute - Dallas
- Colon & Rectal Clinic - Houston
California
- Cedars-Sinai Medical Center - Los Angeles
Kansas
- University of Kansas Medical Center Research Institute, Inc. - Kansas City
Louisiana
- GI Alliance - Baton Rouge - Baton Rouge
New York
- Lenox Hill Hospital PRIME - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2026-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04940611
The ClinicalTrials.gov registry entry for NCT04940611 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,407-participant average among 104 other Crohn's Disease trials with a reported enrollment target (69% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Crohn's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04940611 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Other, Florida, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04940611 about?
NCT04940611 is a clinical study titled "A Study of Surgical Interventions in Fistulizing Conditions". In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The aim of the study is to generate real-world evidence on standard of care for surgical interventions and related outcomes when treating comple...
What is the current status of trial NCT04940611?
This trial is currently active not recruiting. The enrollment target is 750 participants. The study started on 2021-08-05. Estimated completion is 2026-05-02.
What conditions does trial NCT04940611 study?
This clinical trial studies the following conditions: Crohn's Disease, Fistula, Complex Perianal Fistula, Rectovaginal Fistula, Complex Cryptoglandular Fistula.
Who is sponsoring clinical trial NCT04940611?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04940611 being conducted?
This trial has 20 study locations across California, Florida, Kansas, Louisiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
RECRUITING · NA
-
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RECRUITING · Phase 2
-
Behavioral Therapy for Crohn's Disease
RECRUITING · NA
-
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
RECRUITING · Phase 3
-
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RECRUITING · Phase 4
-
Helmsley 3.0: Abbreviated MRE
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.